
The availability of anti‐osteoporosis medications with rapid onset and high potency requires tools to identify patients at high imminent fracture risk (IFR). There are few tools that predict a patient's IFR. We aimed to develop and validate tools for patients with a recent fracture and for patients initiating oral bisphosphonate therapy. The proposed IFR prediction models could be used to identify more precisely patients at high imminent risk of fracture and inform anti‐osteoporosis treatment selection. The freely available model parameters permit local validation and implementation.
Like
Save
Share